DIA
FOLD

Denver Investment Advisors’s Amicus Therapeutics FOLD Stock Holding History

Denver Investment Advisors’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$504K Buy
33,537
+1,750
+6% +$26.6K 0.03% 319
2017
Q4 		$457K Buy
+31,787
New +$437K 0.02% 328

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Denver Investment Advisors's FOLD Position: Q1 2018 in Review

Denver Investment Advisors increased its Amicus Therapeutics (FOLD) stake by 5.5% in Q1 2018, buying an estimated $26.6K and bringing the position to 33,537 shares worth $504K. The position accounts for 0.03% of the portfolio, ranked #319.

Denver Investment Advisors first reported a position in FOLD in Q4 2017 and has held it in 2 quarters since. 203 funds tracked by Wall St. Rank hold FOLD as of Q1 2018.

  • Denver Investment Advisors held 33,537 shares of Amicus Therapeutics worth $504K as of Q1 2018.
  • Denver Investment Advisors bought 1,750 Amicus Therapeutics shares in Q1 2018, an estimated $26.6K.
  • Amicus Therapeutics made up 0.03% of Denver Investment Advisors's portfolio in Q1 2018, its #319 holding.
  • Denver Investment Advisors first reported a position in Amicus Therapeutics in Q4 2017 and has held it in 2 quarters since.
  • 203 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2018.

Based on Denver Investment Advisors's 13F filing for Q1 2018, filed 10 May 2018.